LOPATOL 100 DIN 00623016
Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | NITROSCANATE 100 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1988 |
|---|
| Current status date | 30-Jul-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NITROSCANATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00623024 | LOPATOL 500 | ELANCO CANADA LIMITED | Tablet | NITROSCANATE 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 18175 | 2016-06-14 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 6838 | 1998-10-13 | New Drug Submission (NDS) | |
Request a quote for LOPATOL 100
How to read a Canadian DIN record